Gülgün Büyükdereli1, Mehtap Güler2, Gülşah Şeydaoğlu3. 1. Department of Nuclear Medicine, Çukurova University School of Medicine, Adana, Turkey. 2. Department of Nuclear Medicine, State Hospital, Niğde, Turkey. 3. Department of Biostatistics, Çukurova University School of Medicine, Adana, Turkey.
Abstract
BACKGROUND: 18F-fluorodeoxyglucose (FDG) positron emission tomography computed tomography (PET/CT) provides information about metabolic and morphologic status of malignancies. Tumor size and standardized uptake value (SUV) measurements are crucial for cancer treatment monitoring. AIMS: The purpose of our study was to assess the variability of these measurements performed by observers evaluating lung tumors. STUDY DESIGN: Retrospective cross-sectional study. METHODS: FDG PET/CT images of 97 patients with pulmonary tumors were independently evaluated by two experienced nuclear medicine physicians. Primary tumor size (UDCT), maximum SUV (SUVmax), mean SUV (SUVmean) and maximum SUV normalized to liver mean SUV (SUVnliv max) were measured by each observer at two different times with an interval of at least 2 weeks. Interobserver and intraobserver variabilities of measurements were evaluated through statistical methods. RESULTS: Size of the lesions varied from 0.81 to 13.6 cm (mean 4.29±2.24 cm). Very good agreement was shown with correlation, Bland-Altman and regression analysis for all measured PET/CT parameters. In the interobserver and intraobserver variability analysis, the Pearson correlation coefficients were greater than 0.96 and 0.98, respectively. CONCLUSION: Semi-quantitative measurements of pulmonary tumors were highly reproducible when determined by experienced physicians with clinically available software for routine FDG PET/CT evaluation. Consistency may be improved if the same observer performs serial measurements for any one patient.
BACKGROUND:18F-fluorodeoxyglucose (FDG) positron emission tomography computed tomography (PET/CT) provides information about metabolic and morphologic status of malignancies. Tumor size and standardized uptake value (SUV) measurements are crucial for cancer treatment monitoring. AIMS: The purpose of our study was to assess the variability of these measurements performed by observers evaluating lung tumors. STUDY DESIGN: Retrospective cross-sectional study. METHODS:FDG PET/CT images of 97 patients with pulmonary tumors were independently evaluated by two experienced nuclear medicine physicians. Primary tumor size (UDCT), maximum SUV (SUVmax), mean SUV (SUVmean) and maximum SUV normalized to liver mean SUV (SUVnliv max) were measured by each observer at two different times with an interval of at least 2 weeks. Interobserver and intraobserver variabilities of measurements were evaluated through statistical methods. RESULTS: Size of the lesions varied from 0.81 to 13.6 cm (mean 4.29±2.24 cm). Very good agreement was shown with correlation, Bland-Altman and regression analysis for all measured PET/CT parameters. In the interobserver and intraobserver variability analysis, the Pearson correlation coefficients were greater than 0.96 and 0.98, respectively. CONCLUSION: Semi-quantitative measurements of pulmonary tumors were highly reproducible when determined by experienced physicians with clinically available software for routine FDG PET/CT evaluation. Consistency may be improved if the same observer performs serial measurements for any one patient.
Authors: Wayne L Monsky; Vassilios Raptopoulos; Mary T Keogan; David Doty; Ihab Kamel; Chun Sam Yam; Bernard J Ransil Journal: Eur Radiol Date: 2003-12-05 Impact factor: 5.315
Authors: Edith M Marom; Reginald F Munden; Mylene T Truong; Gregory W Gladish; Donald A Podoloff; Osama Mawlawi; Lyle D Broemeling; John F Bruzzi; Homer A Macapinlac Journal: J Thorac Imaging Date: 2006-08 Impact factor: 3.000
Authors: Corneline J Hoekstra; Sigrid G Stroobants; Egbert F Smit; Johan Vansteenkiste; Harm van Tinteren; Pieter E Postmus; Richard P Golding; Bonne Biesma; Frans J H M Schramel; Nico van Zandwijk; Adriaan A Lammertsma; Otto S Hoekstra Journal: J Clin Oncol Date: 2005-11-20 Impact factor: 44.544
Authors: H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price Journal: Eur J Cancer Date: 1999-12 Impact factor: 9.162
Authors: Christopher Scarfone; William C Lavely; Anthony J Cmelak; Dominique Delbeke; William H Martin; Dean Billheimer; Dennis E Hallahan Journal: J Nucl Med Date: 2004-04 Impact factor: 10.057
Authors: Mubarik A Arshad; Andrew Thornton; Haonan Lu; Henry Tam; Kathryn Wallitt; Nicola Rodgers; Andrew Scarsbrook; Garry McDermott; Gary J Cook; David Landau; Sue Chua; Richard O'Connor; Jeanette Dickson; Danielle A Power; Tara D Barwick; Andrea Rockall; Eric O Aboagye Journal: Eur J Nucl Med Mol Imaging Date: 2018-09-01 Impact factor: 9.236